The effect of adenomyosis on the outcomes of laparoscopic hysterectomy
- PMID: 27651723
- PMCID: PMC5019831
- DOI: 10.5152/jtgga.2016.16073
The effect of adenomyosis on the outcomes of laparoscopic hysterectomy
Abstract
Objective: The presence of adenomyosis (ADS) may increase complication rates associated with laparoscopic hysterectomy (LH) due to an increased weight of the uterus, increased vascularization of the uterus, impaired myometrial tissue, and presence of additional gynecological pathologies such as leiomyoma or endometriosis. The aim of the present study was to evaluate perioperative and early postoperative parameters in patients with or without adenomyotic lesions.
Material and methods: The study included patients who underwent LH in a university hospital. Patient data were retrieved from the hospital records and reviewed retrospectively. Sixty-one patients (85.9%) without adenomyotic lesions comprised the control group. Ten patients with adenomyotic lesions (14.1%) were regarded as the study group.
Results: In this study, the mean age of the patients was 50.93±9.39 years. The mean uterus size was significantly higher in patients with ADS (p=0.02). There was no statistically significant difference in perioperative variables such as delta hemoglobin (Hb), insertion of pelvic drainage catheter, and invasive assessment of the urinary tract between both the groups (p=0.27, p=1.0, and p=0.67, respectively). The difference between the groups in terms of postoperative blood transfusion was not statistically significant (p=0.25). There was no statistically significant difference in the postoperative maximum body temperature, length of hospital stay, and duration of urinary catheterization between both the groups (p=0.77, p=0.36, and p=0.75, respectively).
Conclusion: LH appears to be a safe alternative for patients with ADS. Large-scale, prospective, and randomized trials are required in order to suggest the routine use of LH in patients preoperatively diagnosed with ADS.
Keywords: Adenomyosis; laparoscopic hysterectomy; outcomes.
Similar articles
-
Transumbilical single-incision laparoscopic hysterectomy with conventional laparoscopic instruments in patients with symptomatic leiomyoma and/or adenomyosis.Arch Gynecol Obstet. 2011 Oct;284(4):893-900. doi: 10.1007/s00404-010-1770-0. Epub 2010 Nov 30. Arch Gynecol Obstet. 2011. PMID: 21116641
-
Evaluation of the outcomes of laparoscopic hysterectomy for normal and enlarged uterus (>280 g).Arch Gynecol Obstet. 2014 Apr;289(4):831-7. doi: 10.1007/s00404-013-3065-8. Epub 2013 Nov 1. Arch Gynecol Obstet. 2014. PMID: 24178482
-
Multi-institution, Prospective, Randomized Trial to Compare the Success Rates of Single-port Versus Multiport Laparoscopic Hysterectomy for the Treatment of Uterine Myoma or Adenomyosis.J Minim Invasive Gynecol. 2015 Jul-Aug;22(5):785-91. doi: 10.1016/j.jmig.2015.02.022. Epub 2015 Mar 7. J Minim Invasive Gynecol. 2015. PMID: 25757810 Clinical Trial.
-
Pelvic pain and patient satisfaction after laparoscopic supracervical hysterectomy: prospective trial.J Minim Invasive Gynecol. 2014 May-Jun;21(3):406-11. doi: 10.1016/j.jmig.2013.10.011. Epub 2013 Oct 29. J Minim Invasive Gynecol. 2014. PMID: 24177452
-
Single-Port vs Multiport Laparoscopic Hysterectomy: A Meta-Analysis of Randomized Controlled Trials.J Minim Invasive Gynecol. 2016 Nov-Dec;23(7):1049-1056. doi: 10.1016/j.jmig.2016.08.826. Epub 2016 Aug 30. J Minim Invasive Gynecol. 2016. PMID: 27590569 Review.
Cited by
-
Recurrence-associated factors of laparoscopic adenomyomectomy for severely symptomatic adenomyoma.Oncol Lett. 2018 Sep;16(3):3430-3438. doi: 10.3892/ol.2018.9082. Epub 2018 Jul 5. Oncol Lett. 2018. PMID: 30127945 Free PMC article.
-
The Impact of Adenomyosis on Pregnancy.Biomedicines. 2024 Aug 22;12(8):1925. doi: 10.3390/biomedicines12081925. Biomedicines. 2024. PMID: 39200389 Free PMC article. Review.
-
Gynecologists May Underestimate the Amount of Blood Loss during Total Laparoscopic Hysterectomy.Obstet Gynecol Int. 2018 Dec 16;2018:3802532. doi: 10.1155/2018/3802532. eCollection 2018. Obstet Gynecol Int. 2018. PMID: 30647741 Free PMC article.
References
-
- Ferenczy A. Pathophysiology of Adenomyosis. Hum Reprod Update. 1998;4:312–22. http://dx.doi.org/10.1093/humupd/4.4.312. - DOI - PubMed
-
- Parazzini F, Mais V, Cipriani S, Busacca M, Venturini P GISE. Determinants of Adenomyosis in women who underwent hysterectomy for benign gynecological conditions: results from a prospective multicentric study in Italy. Eur J Obstet Gynecol Reprod Biol. 2009;143:103–6. http://dx.doi.org/10.1016/j.ejogrb.2008.12.010. - DOI - PubMed
-
- Li T, Li YG, Pu DM. Matrix metalloproteinase-2 and -9 expression correlated with angiogenesis in human Adenomyosis. Gynecol Obstet Invest. 2006;62:229–35. http://dx.doi.org/10.1159/000094426. - DOI - PubMed
-
- Goteri G, Lucarini G, Montik N, Zizzi A, Stramazzotti D, Fabris G, et al. Expression of vascular endothelial growth factor (VEGF), hypoxia inducible factor-1 alpha (HIF-1 alpha), and microvessel density in endometrial tissue in women with adenomyosis. Int J Gynecol Pathol. 2009;28:157–63. http://dx.doi.org/10.1097/PGP.0b013e318182c2be. - DOI - PubMed
-
- Pepas L, Deguara C, Davis C. Update on the surgical management of Adenomyosis. Curr Opin Obstet Gynecol. 2012;24:259–64. http://dx.doi.org/10.1097/GCO.0b013e328355213a. - DOI - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources